| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |